<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03299829</url>
  </required_header>
  <id_info>
    <org_study_id>EB-TR-001</org_study_id>
    <nct_id>NCT03299829</nct_id>
  </id_info>
  <brief_title>A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients</brief_title>
  <official_title>A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Excelsior</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Excelsior</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective study to assess the clinical efficacy and safety of trientine in
      Wilson's disease patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this retrospective study, the investigators will collect and analyze data from reviewing
      medical history files of larger and long-term follow-up cohorts with Wilson's disease in
      Taiwan to assess the efficacy and safety of Trientine in Taiwanese Wilson's Disease patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The improvement in liver function</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>To measure the AST (aspartate aminotransferase), ALT (alanine transaminase), GGT (gamma-glutamyl transpeptidase), Albumin, and Bilirubin level, and compare to the baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The improvement in urine copper excretion</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>To measure 24-hour urine copper levels during the study period</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Trientine Treatment for Wilson's Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trientine</intervention_name>
    <description>Trientine is a chelating agent for removing the copper from the body</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had the diagnosis of Wilson's disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Wilson's disease.

          -  Male or female patients, aged 3 years to 75 years

        Exclusion Criteria:

          -  Patients with comorbidity which is not related to Wilson's disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chinchang Huange, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kung-Yin Lin, Master</last_name>
    <phone>+886-2+26557568</phone>
    <phone_ext>662</phone_ext>
    <email>cliff.lin@excelsiorgroup.com.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xinyu Huang, Master</last_name>
    <phone>+886-2-2655-7568</phone>
    <phone_ext>663</phone_ext>
    <email>tiffany.huang@excelsiorgroup.com.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital, Linkou</name>
      <address>
        <city>Taoyuan City</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinyu Huang, Master</last_name>
      <phone>+886-2-2655-7568</phone>
      <phone_ext>663</phone_ext>
      <email>tiffany.huang@excelsiorgroup.com.tw</email>
    </contact>
    <contact_backup>
      <last_name>Lijun Chen, Bachelor</last_name>
      <phone>+886-989-684025</phone>
      <email>puppy.7151@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2017</study_first_submitted>
  <study_first_submitted_qc>September 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2017</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trientine</keyword>
  <keyword>Wilson's disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatolenticular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trientine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

